Sarepta Therapeutics, Inc.

By person

16 insiders · 0 transactions

13.5×

Douglas S. Ingram holds 13.5 times base salary in stock. $15.82M of shares against $1.17M in salary for 2025.

Salary from the company's own proxy. The shares are what Douglas S. Ingram last reported holding, valued at $17.02, the price Common Stock was last bought or sold at on the open market here, on 12 Mar 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Barry Richard

Director

—

2,983,542

2.82%

$50.78M

+1.8%

INGRAM DOUGLAS S

Chief Executive Officer

—

929,391

0.8799%

$15.82M

+138.1%

SEVERINO MICHAEL

Chief Executive Officer

—

756,104

0.7158%

$12.87M

—

BEHRENS M KATHLEEN

Director

—

214,357

0.2029%

$3.65M

+12.2%

Rodino-Klapac Louise

President, R&D and Tech Ops

—

203,900

0.1930%

$3.47M

+181.6%

Estepan Ian Michael

Chief Operating Officer

—

177,184

0.1677%

$3.02M

+422.0%

Wong Ryan Ho-Yan

Chief Financial Officer

—

121,792

0.1153%

$2.07M

+589.8%

Rothfuss Cristin

EVP, General Counsel

—

115,519

0.1094%

$1.97M

+738.4%

Nicaise Claude

Director

—

48,407

0.0458%

$823.89K

+166.4%

Wigzell Hans Lennart Rudolf

Director

—

42,098

0.0399%

$716.51K

+84.3%

Murray Dallan

Chief Customer Officer

—

38,202

0.0362%

$650.20K

+71.9%

Arif Bilal

Chief Tech Ops Officer

—

32,500

0.0308%

$553.15K

+85.6%

Chambers Michael Andrew

Director

—

27,535

0.0261%

$468.65K

+232.7%

Boor Kathryn Jean

Director

—

25,138

0.0238%

$427.85K

+234.5%

Connelly Deirdre P

Director

—

22,100

0.0209%

$376.14K

+677.6%

Mayo Stephen

Director

—

18,640

0.0176%

$317.25K

+181.5%

Sarepta Therapeutics, Inc.

By person

Individual transactions

What was left out